T Yamashita Selected Research

T Yamashita Research Topics

Disease

32	Neoplasms (Cancer) 01/2021 - 01/2000
12	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2000
11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2000
9	Pain (Aches) 05/2016 - 11/2000
9	Amyloidosis 01/2008 - 02/2000
8	Polyneuropathies (Polyneuropathy) 06/2011 - 02/2000
8	Thrombosis (Thrombus) 05/2006 - 03/2000
7	Inflammation (Inflammations) 04/2019 - 03/2000
6	Type 2 Diabetes Mellitus (MODY) 10/2017 - 01/2000
6	Infections 04/2016 - 05/2000
5	Systemic Scleroderma (Systemic Sclerosis) 04/2019 - 02/2016
5	Fibrosis (Cirrhosis) 02/2018 - 07/2000
5	Head and Neck Neoplasms (Head and Neck Cancer) 11/2017 - 08/2000
5	Squamous Cell Carcinoma of Head and Neck 04/2015 - 08/2000
5	Necrosis 02/2011 - 04/2000
4	Stroke (Strokes) 01/2014 - 05/2003
4	Lymphoma (Lymphomas) 06/2013 - 06/2000
4	Pathologic Constriction (Stenosis) 06/2011 - 04/2000
4	Stomach Neoplasms (Stomach Cancer) 04/2006 - 06/2000
4	Habitual Abortion (Recurrent Miscarriage) 11/2001 - 02/2000
3	Hyperglycemia 01/2020 - 01/2001
3	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2018 - 02/2016
3	Body Weight (Weight, Body) 11/2017 - 05/2001
3	Dementia (Dementias) 01/2017 - 05/2003
3	Radiculopathy (Radiculopathy, Cervical) 05/2016 - 05/2003
3	Hematologic Neoplasms (Hematological Malignancy) 04/2016 - 02/2000
3	Hypoxia (Hypoxemia) 02/2015 - 02/2001
3	Insulin Resistance 02/2015 - 01/2001
3	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 09/2001
3	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 02/2012 - 06/2011
3	Atherosclerosis 03/2010 - 01/2001
3	Osteosarcoma (Osteogenic Sarcoma) 06/2009 - 03/2002
3	Amyloid Plaque 01/2008 - 04/2000
3	Hypersensitivity (Allergy) 12/2007 - 07/2001
3	Congenital Abnormalities (Deformity) 09/2006 - 01/2001
3	Carcinoma (Carcinomatosis) 10/2001 - 06/2000
3	Melanoma (Melanoma, Malignant) 10/2001 - 06/2000
3	Leukemia 06/2001 - 02/2000
3	Vascular Remodeling 03/2001 - 02/2001
2	Cytopenia 01/2022 - 01/2007
2	Sensorineural Hearing Loss 06/2021 - 10/2000
2	Diarrhea 01/2020 - 04/2000
2	Osteoarthritis 01/2019 - 02/2014
2	Osteoporosis 12/2018 - 04/2001
2	Schizophrenia (Dementia Praecox) 01/2017 - 01/2017
2	Autism Spectrum Disorder 01/2017 - 01/2017
2	Neuralgia (Stump Neuralgia) 05/2016 - 03/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2015 - 03/2011
2	Esophageal Neoplasms (Esophageal Cancer) 02/2014 - 03/2000

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 12/2013 - 03/2000
11	Prealbumin (Transthyretin)IBA 02/2012 - 02/2000
9	Amyloid (Amyloid Fibrils)IBA 06/2011 - 04/2000
7	CytokinesIBA 02/2011 - 03/2000
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2000
6	Messenger RNA (mRNA)IBA 01/2014 - 02/2000
5	Hormones (Hormone)IBA 01/2022 - 11/2001
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2000
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2010 - 02/2000
5	DNA (Deoxyribonucleic Acid)IBA 02/2007 - 07/2001
4	Codon (Codons)IBA 01/2016 - 03/2001
4	RNA (Ribonucleic Acid)IBA 11/2014 - 02/2000
4	Matrix Metalloproteinases (MMPs)IBA 09/2012 - 08/2000
4	InterleukinsIBA 02/2011 - 08/2000
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009 - 01/2001
4	EnzymesIBA 06/2009 - 01/2001
4	Biological ProductsIBA 01/2006 - 04/2000
3	Fulvestrant (Faslodex)FDA Link 01/2021 - 06/2017
3	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 10/2000
3	SteroidsIBA 04/2016 - 09/2001
3	Transcription Factors (Transcription Factor)IBA 04/2015 - 03/2001
3	Pharmaceutical PreparationsIBA 01/2014 - 10/2009
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2012 - 11/2000
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2011 - 06/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 02/2001
3	ImmunosorbentsIBA 06/2009 - 11/2001
3	AntigensIBA 04/2002 - 06/2000
3	Interleukin-4 (Interleukin 4)IBA 12/2001 - 03/2000
3	Peptides (Polypeptides)IBA 11/2001 - 06/2000
3	NF-kappa B (NF-kB)IBA 10/2001 - 07/2000
3	Fluorouracil (Carac)FDA LinkGeneric 03/2001 - 07/2000
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 01/2021
2	AlpelisibIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 12/2009
2	GangliosidesIBA 01/2019 - 02/2014
2	Blood Glucose (Blood Sugar)IBA 08/2017 - 02/2015
2	rho-Associated KinasesIBA 01/2017 - 01/2004
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2015 - 01/2005
2	Oxygen (Dioxygen)IBA 02/2015 - 05/2006
2	Indicators and Reagents (Reagents)IBA 01/2014 - 01/2001

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2000
7	Radiotherapy 11/2017 - 03/2000
7	Transplantation 07/2011 - 06/2004
6	Liver Transplantation 02/2012 - 04/2000
5	Lasers (Laser) 01/2005 - 11/2000
4	Hematopoietic Stem Cell Transplantation 01/2017 - 06/2004
3	Drug Therapy (Chemotherapy) 06/2017 - 02/2000
3	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2009 - 03/2006
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2001 - 10/2000
2	Stem Cell Transplantation 08/2017 - 06/2000